Drug
Pegylated granulocyte colony-stimulating factor clinical trials
Also written Mecapegfilgrastim.
- studies test it
- 39
- open now
- 11
- in phase 3
- 3
- first study started
- 2013
Keep track of what changes. Save the pegylated granulocyte colony-stimulating factor studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Other names
Studies by the year they started
39 studies that test it; most in 2022 (9)
| Year | Studies |
|---|---|
| 2013 | 4 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 9 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 2
- Phase 2
- 5
- Phase 3
- 3
- Phase 4
- 14
- No phase
- 14
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 27
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. (10) · Peking University (4) · The Affiliated People's Hospital of Ningbo University (3) · Chongqing University Cancer Hospital (2) · Sun Yat-sen University (2) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · Adello Biologics, LLC (1) · Chinese Academy of Medical Sciences (1)
Often tested with
Tested in the same studies.
Etoposide (3) · Cytarabine (3) · Pegfilgrastim (1) · Choline (1) · Cromolyn (1) · Efavirenz (1) · Trastuzumab rezetecan (1) · Notiretatug rezetecan (1)
Studies
Open first, then newest update. How each study uses pegylated granulocyte colony-stimulating factor is read from its arms, and is right about nine times in ten.
Testing it · 39
- Reverse Triple Negative Immune Resistant Breast CancerRecruitingPhase 2Fudan UniversityNCT05076682Written as Mecapegfilgrastim
- Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor ChemoradiotherapyRecruitingPhase 2Affiliated Hospital of Nantong UniversityNCT07205536Written as Mecapegfilgrastim injection
- Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for LymphomaRecruitingPhase 3The Affiliated People's Hospital of Ningbo UniversityNCT06520163Written as PEG-rhG-CSF
- Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJCNot yet recruitingPhase 2The First Affiliated Hospital with Nanjing Medical UniversityNCT06684158Written as Mecapegfilgrastim
- Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological MalignanciesRecruitingNot applicableThe Affiliated People's Hospital of Ningbo UniversityNCT05536154Written as PEG-rhG-CSF
- The Value of Peripheral Blood CD34+ Cell Dynamics Monitoring in Autologous Hematopoietic Stem Cell Transplant MobilizationNot yet recruitingEarly Phase 1Zhongnan HospitalNCT05970185Written as PEG-rhG-CSF
- Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological MalignanciesRecruitingNot applicableThe Affiliated People's Hospital of Ningbo UniversityNCT05510089Written as PEG-rhG-CSF
- Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple MyelomaRecruitingNot applicableYao LiuNCT06060080Written as pegylated recombinant human granulocyte-colony stimulating factor
- Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem CellsRecruitingPhase 4Chongqing University Cancer HospitalNCT06026995Written as PEG-rhG-CSF
- the Efficacy and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in LymphomaNot yet recruitingNot applicableOu Bai, MD/PHDNCT05834751Written as PEG-rhG-CSF
- A Clinical Study of Autologous Peripheral Blood Stem Cell Mobilization for PEG-G-CSFNot yet recruitingPhase 4Ning HuangNCT05409547Written as PEG-rhG-CSF
- A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid MalignanciesWithdrawnPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT06254742Written as HHPG-19K Injection
- Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast CancerActive, not recruitingPhase 2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT05463601Written as Mecapegfilgrastim
- Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian CancerTerminatedPhase 4Shandong UniversityNCT03858166Written as PEG-rhG-CSF
- Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical CancerCompletedPhase 2Chongqing University Cancer HospitalNCT04542356Written as PEG-rhG-CSF
- A Study of PEG-rhG-CSF and rhG-CSF Used for Aplastic Anemia Granulocyte DeficiencyStatus unknownNot applicableInstitute of Hematology & Blood Diseases Hospital, ChinaNCT05531279Written as PEG-rhG-CSF
- G-CSF in Patients With Anti-PD-1-axis Therapy-resistant Recurrent or Metastatic Nasopharyngeal CarcinomaStatus unknownPhase 1Sun Yat-sen UniversityNCT05222009Written as PEG-rhG-CSF
- PEG-rhG-CSF Compared With rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell TransplantationStatus unknownNot applicableSun Yat-sen UniversityNCT05156554Written as PEG-rhG-CSF
- Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast CancerCompletedPhase 4Peking UniversityNCT04009941Written as PEG-rhG-CSF
- PEG-rhG-CSF in Secondary Prevention of Nab-Paclitaxel Combined With S-1 in Advanced Pancreatic CancerStatus unknownNot applicableChinese PLA General HospitalNCT04518800Written as Jin Youli(PEG-rhG-CSF)
See all 39 studies that test pegylated granulocyte colony-stimulating factor →
Given in every arm · 1 — pegylated granulocyte colony-stimulating factor is usual care beside what is tested
As the comparator · 3 — what is tested is compared with pegylated granulocyte colony-stimulating factor
- Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSFCompletedPhase 2/3Mabwell (Shanghai) Bioscience Co., Ltd.NCT04554056Written as PEG-rhG-CSF
- Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving ChemotherapyCompletedPhase 3Xiamen Amoytop Biotech Co., Ltd.NCT04466137Written as rhG-CSF/PEG-rhG-CSF
- Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving ChemotherapyCompletedPhase 2Xiamen Amoytop Biotech Co., Ltd.NCT02005458Written as PEG-rhG-CSF, 100μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle
Codes
What other systems call pegylated granulocyte colony-stimulating factor · ClinicalTrials.gg INT004328
- MeSH (NLM) C423652pegylated granulocyte colony-stimulating factorConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) I4QL0KKG3KMECAPEGFILGRASTIMConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C423652 | pegylated granulocyte colony-stimulating factor | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | I4QL0KKG3K | MECAPEGFILGRASTIM | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.